Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion

Journal of Clinical Investigation

Volumn 119, Issue 12, 2009, Pages 3807-3816

  Qi, Dake ^a   Hu, Xiaoyue ^a   Wu, Xiaohong ^a   Merk, Melanie ^a   Leng, Lin ^a   Bucala, Richard ^a   Young, Lawrence H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; EXPERIMENTAL STUDY; FIBROBLAST; HEART INFARCTION; HEART INJURY; HEART MUSCLE ISCHEMIA; HYPOXIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REOXYGENATION; REPERFUSION INJURY;

ANIMALS; CELL LINE; ENZYME ACTIVATION; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MAP KINASE KINASE 4; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 72849146175     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI39738     Document Type: Article

References (42)

1. Baugh, J.A., et al. 2002. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun. 3:170-176.
2. Burger-Kentischer, A., et al. 2002. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation. 105:1561-1566. (Pubitemid 34297633)
3. Calandra, T., et al. 2000. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6:164-170.
4. Calandra, T., et al. 1995. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 377:68-71.
5. Flaster, H., Bernhagen, J., Calandra, T., and Bucala, R. 2007. The macrophage migration inhibitory factor- glucocorticoid dyad: regulation of inflammation and immunity. Mol. Endocrinol. 21:1267-1280.
6. Takahashi, M., et al. 2002. Elevation of plasma levels of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am. J. Cardiol. 89:248-249.
7. Yu, C.M., Lai, K.W., Chen, Y.X., Huang, X.R., and Lan, H.Y. 2003. Expression of macrophage migration inhibitory factor in acute ischemic myocardial injury. J. Histochem. Cytochem. 51:625-631.
8. Chagnon, F., Metz, C.N., Bucala, R., and Lesur, O. 2005. Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circ. Res. 96:1095-1102.
9. Benigni, F., et al. 2000. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J. Clin. Invest. 106:1291-1300.
10. Miller, E.J., et al. 2008. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature. 451:578-582.
11. Russell, R.R., 3rd, et al. 2004. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J. Clin. Invest. 114:495-503.
12. Weston, C.R., and Davis, R.J. 2007. The JNK signal transduction pathway. Curr. Opin. Cell Biol. 19:142-149.
13. Yin, T., et al. 1997. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J. Biol. Chem. 272:19943-19950.
14. Mizukami, Y., Yoshioka, K., Morimoto, S., and Yoshida, K. 1997. A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion. J. Biol. Chem. 272:16657-16662.
15. Kaiser, R.A., et al. 2005. Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo. J. Biol. Chem. 280:32602-32608.
16. Kleemann, R., et al. 2000. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature. 408:211-216. (Pubitemid 30839423)
17. Nguyen, M.T., et al. 2003. The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. J. Immunol. 170:3337-3347. (Pubitemid 36302213)
18. Watanabe, H., et al. 2004. Ultraviolet A-induced production of matrix metalloproteinase-1 is mediated by macrophage migration inhibitory factor (MIF) in human dermal fibroblasts. J. Biol. Chem. 279:1676-1683.
19. Dhanantwari, P., et al. 2008. Macrophage migration inhibitory factor induces cardiomyocyte apoptosis. Biochem. Biophys. Res. Commun. 371:298-303.
20. Hausenloy, D.J., and Yellon, D.M. 2006. Survival kinases in ischemic preconditioning and post-conditioning. Cardiovasc. Res. 70:240-253.
21. Shao, Z., et al. 2006. c-Jun N-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivo. Circ. Res. 98:111-118.
22. Leng, L., et al. 2003. MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197:1467-1476.
23. Garner, L.B., et al. 2003. Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor. Am. J. Physiol. Heart Circ. Physiol. 285:H2500-H2509.
24. Qi, X., Vallentin, A., Churchill, E., and Mochly- Rosen, D. 2007. deltaPKC participates in the endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart. J. Mol. Cell. Cardiol. 43:420-428.
25. Aoki, H., et al. 2002. Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J. Biol. Chem. 277:10244-10250.
26. Bennett, B.L., et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 98:13681-13686.
27. Heidbreder, M., Naumann, A., Tempel, K., Dominiak, P., and Dendorfer, A. 2008. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways. Cardiovasc. Res. 78:108-115.
28. Schulz, E., et al. 2008. Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction. Circulation. 118:1347-1357.
29. Willis, M.S., et al. 2005. Macrophage migration inhibitory factor mediates late cardiac dysfunction after burn injury. Am. J. Physiol. Heart Circ. Physiol. 288:H795-H804.
30. Pakozdi, A., et al. 2006. Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase- 2 production in rheumatoid arthritis. Arthritis Res. Ther. 8:R132.
31. Santini, E., et al. 2008. Effects of different LDL particles on inflammatory molecules in human mesangial cells. Diabetologia. 51:2117-2125.
32. Bogoyevitch, M.A., et al. 1996. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogenactivated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ. Res. 79:162-173.
33. Zhao, J., Pei, D.S., Zhang, Q.G., and Zhang, G.Y. 2007. Down-regulation Cdc42 attenuates neuronal apoptosis through inhibiting MLK3/JNK3 cascade during ischemic reperfusion in rat hippocampus. Cell Signal. 19:831-843. (Pubitemid 46275373)
34. Zhang, Q.G., et al. 2006. Akt inhibits MLK3/JNK3 signaling by inactivating Rac1: a protective mechanism against ischemic brain injury. J. Neurochem. 98:1886-1898.
35. Zhang, Q.G., et al. 2005. Knock-down of POSH expression is neuroprotective through down-regulating activation of the MLK3-MKK4-JNK pathway following cerebral ischaemia in the rat hippocampal CA1 subfield. J. Neurochem. 95:784-795.
36. Watanabe, T., et al. 2005. Apoptosis signal-regulating kinase 1 is involved not only in apoptosis but also in non-apoptotic cardiomyocyte death. Biochem. Biophys. Res. Commun. 333:562-567.
37. Frazier, D.P., et al. 2007. PKC-alpha and TAK-1 are intermediates in the activation of c-Jun NH2- terminal kinase by hypoxia-reoxygenation. Am. J. Physiol. Heart Circ. Physiol. 292:H1675-1684.
38. Dhanasekaran, D.N., and Reddy, E.P. 2008. JNK signaling in apoptosis. Oncogene. 27:6245-6251.
39. Mizue, Y., et al. 2005. Role for macrophage migration inhibitory factor in asthma. Proc. Natl. Acad. Sci. U. S. A. 102:14410-14415.
40. Plant, B.J., et al. 2005. Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism. Am. J. Respir. Crit. Care Med. 172:1412-1415.
41. Bernhagen, J., et al. 2007. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13:587-596.
42. Das, S., Otani, H., Maulik, N., and Das, D.K. 2006. Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling. J. Mol. Cell. Cardiol. 41:248-255.